-
GE Healthcare VP acknowledges China's outstanding market appeal
2023-10-13
China has always been one of the world's most promising large markets. Robust market demand, a comprehensive industrial chain, and rapidly growing innovation capabilities have made the Chinese market a vital driving force for the expansion of many global healthcare giants and a significant source for their profit growth.
-
Sanofi shows long-term commitment to China
2023-10-12
Paul Hudson, CEO of Sanofi, was recently interviewed regarding the company's development, opportunities and localization strategy in the Chinese market as well as new features and trends in the global pharmaceutical market.
-
AstraZeneca's 30 years in China: Building a sustainable health ecosystem
2023-10-11
During the first decade (1993-2003) following its entry into China, AstraZeneca held a strong belief in the vast market potential of the country, according to Wang Lei, the company's global executive vice-president and president of AstraZeneca China. During the subsequent decade (2003-2013), AstraZeneca's strategic focus developed towards manufacturing in China, resulting in the establishment of production facilities in Wuxi and Taizhou in Jiangsu province.
-
BDA earns accolades for streamlined approval services
2023-09-26
Günter Wehrle, head of Investment Project Department at Bayer Beijing Plant, presents a silk banner to the Administrative Examination and Approval Bureau on November 3, 2021.
-
Address
Boda Building, No.15, Ronghua Middle Road, Beijing Economic-Technological Development Area
-
Email
investinbda@bda.gov.cn
-
TEL
+86-010-86409333(24h)
-
FAX
+86-010-67881207